Vitro, S.A. (VITROA) Fair Value & Analysis
Basic Materials · MX · Market cap 2.4B MXN
Fair value as of: Jul 20, 2026
From 23 valuation models · updated 21 days ago
Share price −7.3% over the past month.
A solid business, but screening 81% overvalued on our models.
What matters now
- A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
- The price sits above even our optimistic bull case (1.43 MXN). The favourable scenario is already priced in.
- A fairly wide model range (0.7400 MXN to 1.43 MXN) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 3.70 MXN – 36.61 MXN · fair‑value band 0.7400 MXN – 1.43 MXN · the 5.10 MXN price screens above the 0.9900 MXN fair value. Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Vitro, S.A. (VITROA) currently trades at 5.10 MXN, while our model-based Fair Value estimate is 0.9900 MXN, implying the stock looks roughly 80.6% overvalued today. The Quality Score stands at 70/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Vitro, S.A. generated revenue of 284M MXN at a net margin of 60.6%. Revenue grew 15.5% year over year. It earns a return on equity of 17.3%. Net debt stands at 74.8M MXN. Fundamentals as of Jul 20, 2026
Our scenario range runs from 0.7400 MXN (bear case) to 1.43 MXN (bull case); at 5.10 MXN, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 38% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -59% fair-value upside, at -81%, VITROA screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: Growth DCF (6.85 MXN) versus Earnings-Based (0.2400 MXN). Highest evidence: Growth DCF (80).
Notify me when VITROA reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 32
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.
Full company description
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.B. de C.V. was founded in 1909 and is based in San Pedro Garza García, Mexico.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
Vitro, S.A. reported revenue of 311M MXN in FY2023 versus 2.2B MXN in FY2019, a compound −38.6%/yr. Reported net income was 129M MXN in FY2023, compounding +19.1%/yr from FY2019.
VITROA screens 81% overvalued. Compare with CRH plc →
Peer Group
Building Materials · 253 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Building Materials median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 35/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CRH plc CRH | $102.92 | $70.57 | -31% |
| UltraTech Cement Limited ULTRACEMCO | ₹11,711 | ₹4,719 | -60% |
| China Jushi Co 600176 | ¥54.52 | ¥13.95 | -74% |
| Grasim Industries Limited GRASIM | ₹3,073 | ₹1,245 | -59% |
| CEMEX, S.A. CEMEXCPO | 21.71 MXN | 15.42 MXN | -29% |
| Anhui Conch Cement Company 600585 | ¥16.99 | ¥26.14 | +54% |
| Ambuja Cements Limited AMBUJACEM | ₹435.25 | ₹227.96 | -48% |
| Shree Cement Limited SHREECEM | ₹26,930 | ₹8,215 | -69% |
| TCC Group 1101B | 43.70 TWD | 10.48 TWD | -76% |
| Taiwan Glass Ind. Corp 1802 | 53.30 TWD | 13.98 TWD | -74% |
Compare Vitro, S.A. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Vitro, S.A. (VITROA) overvalued or undervalued?
What is the fair value of VITROA?
What is the quality score of VITROA?
What is the revenue of Vitro, S.A. (VITROA)?
What is the net profit margin of VITROA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Vitro, S.A. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.